.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
AI in healthcare must be a collaborative effort between tech innovators and medical professionals. Dr. VK Paul from Niti Aayog recently highlighted this necessity at the AI Impact Summit in New Delhi. He argued that validation is the only way to ensure these tools are safe for public use. Therefore, clinical expertise must guide every stage of the development process. Consequently, innovators can avoid the pitfalls of developing technology in isolation.
Innovators should not work in silos. Instead, they must partner with clinicians, radiologists, and public health experts. This partnership ensures that products meet specific medical needs. Furthermore, validation metrics like sensitivity and specificity remain vital for measuring performance. Dr. Paul noted that the government wishes to build a culture of responsible adoption. However, this progress requires alignment with existing legal and regulatory frameworks. Moreover, the goal is to provide oversight that protects patient safety.
He further emphasized that any validated tool would be absorbed into the national health system. This process follows a rigorous health technology assessment. Consequently, such tools will eventually become public goods for all citizens. This move aims to democratize high-quality care across rural and urban divides. Hence, clinical researchers and trial experts must be involved from the start.
Dr. Harsh Mahajan, a renowned radiologist, echoed these sentiments during the panel discussion. He stated that AI in healthcare can be highly beneficial only if used ethically. Crucially, these tools must remain under the supervision of trained professionals. He warned against the public using platforms like ChatGPT for self-diagnosis, citing potential clinical risks. Similarly, modern imaging equipment already incorporates AI to reduce radiation and improve scan quality. However, human judgment remains irreplaceable in interpreting complex data.
Nico Schiettekatte from the Netherlands Embassy added that technology must solve real problems. We must evaluate whether these interventions actually improve patient recovery outcomes. Therefore, the focus should shift from mere experimentation to large-scale implementation. Finally, ensuring that AI serves humanity is the ultimate goal of these foundational shifts.
Q1: Why is clinical co-creation vital for AI in healthcare?
Innovators often lack clinical context. Therefore, partnering with doctors ensures tools are medically sound, ethically developed, and meet strict regulatory standards.
Q2: What role does Niti Aayog play in adopting AI tools?
Niti Aayog assesses validated tools through health technology assessments. Consequently, they integrate these tools into the public health system as scalable public goods.
Q3: Is it safe for patients to use general AI for self-diagnosis?
No, experts warn that self-diagnosis using tools like ChatGPT is risky. Professional medical supervision is necessary to ensure patient safety and accurate diagnosis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Niti Aayog’s Dr. VK Paul urges innovators to co-create AI with medical experts, ensuring clinical validation and regulatory compliance for safe health adopt...
6 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
